|
|
Volumn 57, Issue 3, 2008, Pages 332-337
|
|
High-level carbapenem resistance in a Citrobacter freundii clinical isolate is due to a combination of KPC-2 production and decreased porin expression
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AMIKACIN;
AMPICILLIN;
AZTREONAM;
BACTERIAL DNA;
BACTERIAL ENZYME;
BETA LACTAMASE;
BETA LACTAMASE CTX M 14;
BETA LACTAMASE KPC 2;
BETA LACTAMASE TEM 1;
CARBAPENEM;
CARBAPENEM DERIVATIVE;
CEFEPIME;
CEFOTAXIME;
CEFOXITIN;
CEFTAZIDIME;
CEFTRIAXONE;
CEPHALOSPORIN DERIVATIVE;
CIPROFLOXACIN;
GENTAMICIN;
IMIPENEM;
MEROPENEM;
PENICILLIN DERIVATIVE;
PIPERACILLIN;
PIPERACILLIN PLUS TAZOBACTAM;
PORIN;
SULPERAZON;
UNCLASSIFIED DRUG;
ANTIBIOTIC RESISTANCE;
ANTIBIOTIC SENSITIVITY;
ARTICLE;
BACTERIUM ISOLATE;
CITROBACTER FREUNDII;
CONTROLLED STUDY;
DNA SEQUENCE;
ENZYME ACTIVITY;
ESCHERICHIA COLI;
ISOELECTRIC FOCUSING;
MINIMUM INHIBITORY CONCENTRATION;
NONHUMAN;
PRIORITY JOURNAL;
PROTEIN EXPRESSION;
PROTEIN FUNCTION;
PROTEIN SYNTHESIS;
ANTI-BACTERIAL AGENTS;
BETA-LACTAMASES;
CARBAPENEMS;
CITROBACTER FREUNDII;
CONJUGATION, GENETIC;
DRUG RESISTANCE, BACTERIAL;
HUMANS;
IMIPENEM;
MICROBIAL SENSITIVITY TESTS;
MOLECULAR SEQUENCE DATA;
PLASMIDS;
POLYMERASE CHAIN REACTION;
PORINS;
SEQUENCE ANALYSIS, DNA;
|
|
EID: 40549135623
PISSN: 00222615
EISSN: None
Source Type: Journal
DOI: 10.1099/jmm.0.47576-0 Document Type: Article |
|
Times cited : (65)
|
|
References (22)
|
